【ETF Trends】On February 25th, Yin Hua CSI Innovation Drug Industry ETF increased by 0.72%, with a decrease of 122 million shares

robot
Abstract generation in progress

Securities Star News: On February 25, the Yin Hua CSI Innovative Drug Industry ETF (159992) rose by 0.72%, with a trading volume of 489 million yuan. That day, the fund’s shares decreased by 122 million, with the latest total shares at 17.995 billion, an increase of 998 million shares over the past 20 trading days. The net capital inflow was 17.99 million yuan (calculated as the difference between the asset net value on the day and the previous trading day’s asset net value). The latest asset net value is 15.008 billion yuan. The Yin Hua CSI Innovative Drug Industry ETF tracks the CSI Innovative Drug Industry Index. Since its inception on March 20, 2020, it has an excess return of -7.53%, and over the past month, an excess return of -0.02%. The fund is managed by Yin Hua Fund Company, with fund managers Ma Jun and Wang Shuai.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)